4
Changes in Ownership
ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-21-003321
Chief Medical Officer acquired 224,529 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schwartz Jonathan David · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-01 | Exercise or conversion : show line 1 in the form | +11,428 | $1.69 | $19,313 | 11,428 | D |
| 2021-02-01 | Exercise or conversion : show line 2 in the form | +213,101 | $1.21 | $257,852 | 224,529 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-02-01 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −11,428 | $1.69 | 2027-04-12 | 11,428 | 0 | D |
| 2020-02-10 | Returned to the company : show line 4 in the form Stock Option (Right to Buy) | −213,101 | $1.21 | 2026-02-08 | 213,101 | 38,309 | D |
Loading xslF345X03/form4.xml…